Since the first review article on bacterial biofilm formation was published in 1990 [1] , this field of research has still been expanding exponentially, as seen by the number of publications, which almost exceeded 2,000 articles in 2018. The reason why this topic is receiving so much attention is easy to explain: biofilm formation contributes to antibiotic resistance and tolerance in pathogenic bacteria [2] . Thus, also the Journal of Innate Immunity has recently devoted increasing attention to this topic [3] [4] [5] [6] [7] [8] . Notably, the extracellular matrix plays an important role in the formation of biofilms, since it provides a surface for bacteria to attach to and colonize.
In this issue, Binsker et al. [9] provide an excellent summary of the contribution of human thrombospondin-1 to the pathogenesis of gram-positive bacteria. Thrombospondin-1 is a matricellular protein that is involved in the regulation of extracellular matrix function. As outlined in the review article, in vitro data have shown that Streptococcus pneumoniae and Staphylococcus aureus species interact with thrombospondin-1 in order to adhere to different cells and eventually invade them, but also the interaction with soluble platelet-derived thrombospondin-1 is discussed. Neutrophils are not only important phagocytosing cells, they also play important roles in modulating inflammatory host responses [10] . Moraes et al. [11] report in this issue that the interaction of lowmolecular-weight fucoidan, a polysaccharide extracted from brown algae, with neutrophils can alter their inflammatory responses, making this substance an interesting template for the development of novel anti-inflammatory drugs. Not only eukaryotic cells can release vesicle-like organelles, also bacteria have this ability, as described in an article by Bae et al. [12] . In their study, an unexpected therapeutic use of the bacterial outer membrane vesicles was found, suggesting that these could be applied to provide protection against lethal Influenza A virus infections, as shown in a mouse model. The authors further note that this effect was caused by the mobilization of macrophages, but not neutrophils. Keeping in mind that some influenza infections are associated with high morbidity and mortality [13] , the concept presented by Bae et al. may lead to novel strategies in the treatment of severe viral infections. Macrophages also play an important role in the article published by Muraleedharan et al. [14] . As seen for many other cells [15, 16] , also gene expression in macrophages can be regulated by microRNAs. In their article, Muraleedharan et al. provide evidence that conserved miR-183/96/182 clusters can regulate the production of reactive nitrogen and oxygen species in activated macrophages, which may be an alternative option to combat antibiotic-resistant bacterial infections. Apart from microRNAs, the regulation of macrophages can be altered by many other substances, one of them being bacterial lipopolysaccharide (LPS) [17, 18] . CD14 plays an important role in LPS-induced signaling via toll-like receptors. In their contribution to this issue, Grahnert et al. [19] logical responses by interacting with different subsets of macrophages. Type 1 diabetes is characterized by destruction of insulin-producing pancreatic β cells by cytotoxic T cells. Colli and co-workers [20] show that group B coxsackievirus infection, a putative causative factor for type 1 diabetes, induces ER stress in β cells, promoting a pro-viral response. The findings open new avenues for the treatment of enterovirus-associated diseases. As always, we hope that this collection of articles will increase the interest of the reader in the Journal of Innate Immunity.
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